Abzena Email Format

Pharmaceutical Manufacturing
501-1,000 employees
San Diego, CA, USA

Abzena is a pharmaceutical manufacturing CDMO and CRO specializing in bioconjugates, ADCs, and complex biologics from discovery through commercial launch.

Find contacts at Abzena

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@abzena.com

Company Overview

Industry
Pharmaceutical Manufacturing
Founded
2001
Headquarters
San Diego, CA, USA
Revenue
$250M-$500M
FUNDING Stage
Private
Key Executives
Geoffrey M. Glass (Chief Executive Officer), Thomas Castellano (Chief Financial Officer), Sean O'Brien (Chief Operating Officer (COO) and Site Head, San Diego Operations)

Tech Stack

Microsoft Azure

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Abzena?

Abzena uses the first.last format on abzena.com, so Jane Smith would be jane.smith@abzena.com.

What therapeutic modalities does Abzena support as a CDMO?

Abzena supports monoclonal antibodies, antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), radiopharmaceutical-drug conjugates (RDCs), and vaccines, spanning discovery through commercial manufacturing.

Where are Abzena's manufacturing and development sites located?

Abzena operates sites in San Diego, CA, Bristol, PA, and Cambridge, UK, with each location offering specialized capabilities ranging from bioconjugation and highly potent chemistry to biologics development and early discovery.

How does Abzena's ThioBridge technology differ from standard ADC conjugation methods?

ThioBridge is Abzena's proprietary site-specific conjugation technology that creates stable, homogeneous ADCs without requiring antibody engineering, offering a differentiated alternative to conventional conjugation approaches used across the industry.

How can I find and verify the right Abzena contact for a business development inquiry?

Clay can help you identify and verify the correct Abzena contact by enriching a lead with their confirmed email address following the first.last@abzena.com format, making it straightforward to reach the right person on their business development or scientific team.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles